RPS6 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 2.29949947971875E-10 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.02320000000089E-05 |
Normal-vs-Stage2 |
1.824240E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
2.696100E-03 |
Stage1-vs-Stage2 |
6.718200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
2.370600E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
4.677400E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.45429998546598E-09 |
Normal-vs-AfricanAmerican |
1.235630E-03 |
Normal-vs-Asian |
4.20690000000334E-05 |
Caucasian-vs-AfricanAmerican |
3.734200E-01 |
Caucasian-vs-Asian |
4.940000E-01 |
AfricanAmerican-vs-Asian |
4.025400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.81629999999445E-05 |
Normal-vs-Female |
4.60059999984885E-07 |
Male-vs-Female |
4.255800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.637500E-04 |
Normal-vs-Extreme_Weight |
1.002960E-04 |
Normal-vs-Obese |
8.222200E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
7.831800E-01 |
Normal_Weight-vs-Obese |
6.548600E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
8.503200E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.057800E-01 |
Normal-vs-Age(41-60Yrs) |
3.029800E-04 |
Normal-vs-Age(61-80Yrs) |
3.45020000014351E-07 |
Normal-vs-Age(81-100Yrs) |
1.681000E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.394600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.799200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.201600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.107400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.306630E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.663600E-02 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
9.371600E-01 |
Normal-vs-Grade 3 |
7.648000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
7.479600E-01 |
Grade 2-vs-Grade 4 |
9.371600E-01 |
Grade 3-vs-Grade 4 |
7.648000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.29819999972192E-07 |
Normal-vs-N1 |
2.839600E-02 |
N0-vs-N1 |
6.570000E-01 |
|
|